Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Terminated Phase 1 / 2 Trials for Nivolumab (DB09035)

Also known as: Stage IIIB Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090338 (Stage IIIB Non-Small Cell Lung Cancer AJCC v7)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02846792Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung CancerTreatment